ReposiTrak Inc. (NYSE:TRAK - Get Free Report) CEO Randall K. Fields sold 4,020 shares of the firm's stock in a transaction dated Monday, August 4th. The shares were sold at an average price of $16.29, for a total value of $65,485.80. Following the transaction, the chief executive officer owned 120,480 shares of the company's stock, valued at approximately $1,962,619.20. The trade was a 3.23% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
ReposiTrak Trading Down 1.7%
Shares of ReposiTrak stock traded down $0.28 on Thursday, hitting $16.40. 63,633 shares of the company traded hands, compared to its average volume of 50,692. The company has a 50 day moving average of $19.43. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.03 and a current ratio of 6.03. ReposiTrak Inc. has a 52 week low of $15.12 and a 52 week high of $25.01. The stock has a market cap of $299.79 million, a P/E ratio of 48.24 and a beta of 0.50.
ReposiTrak Cuts Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, August 14th. Shareholders of record on Monday, June 30th will be issued a dividend of $0.0182 per share. The ex-dividend date is Monday, June 30th. This represents a $0.07 dividend on an annualized basis and a yield of 0.4%. ReposiTrak's dividend payout ratio is currently 20.59%.
Institutional Trading of ReposiTrak
Hedge funds have recently bought and sold shares of the stock. R Squared Ltd acquired a new stake in ReposiTrak during the 2nd quarter worth about $235,000. Prescott Group Capital Management L.L.C. lifted its position in ReposiTrak by 47.2% during the 2nd quarter. Prescott Group Capital Management L.L.C. now owns 26,284 shares of the company's stock worth $516,000 after acquiring an additional 8,428 shares during the period. Ellsworth Advisors LLC lifted its position in ReposiTrak by 10.6% during the 1st quarter. Ellsworth Advisors LLC now owns 31,289 shares of the company's stock worth $634,000 after acquiring an additional 2,997 shares during the period. Los Angeles Capital Management LLC acquired a new stake in ReposiTrak during the 2nd quarter worth about $818,000. Finally, Ingalls & Snyder LLC lifted its position in ReposiTrak by 1.3% during the 2nd quarter. Ingalls & Snyder LLC now owns 198,714 shares of the company's stock worth $3,905,000 after acquiring an additional 2,554 shares during the period. Hedge funds and other institutional investors own 27.35% of the company's stock.
Analysts Set New Price Targets
Separately, Wall Street Zen raised shares of ReposiTrak from a "hold" rating to a "buy" rating in a research note on Thursday, May 22nd.
Read Our Latest Report on TRAK
About ReposiTrak
(
Get Free Report)
Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.
Read More

Before you consider ReposiTrak, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ReposiTrak wasn't on the list.
While ReposiTrak currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.